Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet. 2020;395(10229):1054–62.
Guan Wjie, Ni Z yi, Hu Y, Liang W, hua, Ou C, quan, He Jxing et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med [Internet]. 2020 Feb 28 [cited 2022 Jan 10]; Available from: https://www.nejm.org/doi/https://doi.org/10.1056/nejmoa2002032.
Shi Q, Zhang X, Jiang F, Zhang X, Hu N, Bimu C, et al. Clinical characteristics and risk factors for mortality of COVID-19 patients with Diabetes in Wuhan, China: a Two-Center, Retrospective Study. Diabetes Care. 2020;43(7):1382–91.
Article CAS PubMed Google Scholar
Wu Z, McGoogan JM. Characteristics of and important lessons from the Coronavirus Disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239–42.
Article CAS PubMed Google Scholar
Wang S, Ma P, Zhang S, Song S, Wang Z, Ma Y, et al. Fasting blood glucose at admission is an Independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of Diabetes: a multi-centre retrospective study. Diabetologia. 2020;63(10):2102–11.
Article CAS PubMed PubMed Central Google Scholar
Zhang J, Kong W, Xia P, Xu Y, Li L, Li Q, et al. Impaired fasting glucose and Diabetes are related to higher risks of Complications and mortality among patients with Coronavirus Disease 2019. Front Endocrinol. 2020;11:525.
Zhu L, She ZG, Cheng X, Qin JJ, Zhang XJ, Cai J, et al. Association of Blood Glucose Control and outcomes in patients with COVID-19 and pre-existing type 2 Diabetes. Cell Metab. 2020;31(6):1068–1077e3.
Article CAS PubMed PubMed Central Google Scholar
Klein SJ, Mayerhöfer T, Fries D, Preuß Hernández C, Joannidis M, Bellmann R, et al. Elevated HbA1c remains a predominant finding in severe COVID-19 and may be associated with increased mortality in patients requiring mechanical ventilation. Crit Care. 2021;25(1):300.
Article PubMed PubMed Central Google Scholar
Wang Z, Du Z, Zhu F. Glycosylated hemoglobin is associated with systemic inflammation, hypercoagulability, and prognosis of COVID-19 patients. Diabetes Res Clin Pract [Internet]. 2020 Jun 1 [cited 2021 Nov 15];164. Available from: https://www.diabetesresearchclinicalpractice.com/article/S0168-8227(20)30464-2/fulltext.
Falciglia M, Freyberg RW, Almenoff PL, D’Alessio DA, Render ML. Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis. Crit Care Med. 2009;37(12):3001–9.
Article CAS PubMed PubMed Central Google Scholar
Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an Independent marker of in-hospital mortality in patients with undiagnosed Diabetes. J Clin Endocrinol Metab. 2002;87(3):978–82.
Article CAS PubMed Google Scholar
Eslami S, Taherzadeh Z, Schultz MJ, Abu-Hanna A. Glucose variability measures and their effect on mortality: a systematic review. Intensive Care Med. 2011;37(4):583–93.
Article PubMed PubMed Central Google Scholar
Hermanides J, Vriesendorp TM, Bosman RJ, Zandstra DF, Hoekstra JB, Devries JH. Glucose variability is associated with intensive care unit mortality. Crit Care Med. 2010;38(3):838–42.
Article CAS PubMed Google Scholar
Egi M, Bellomo R, Stachowski E, French CJ, Hart G. Variability of blood glucose concentration and short-term mortality in critically Ill patients. Anesthesiology. 2006;105(2):244–52.
Article CAS PubMed Google Scholar
Ali NA, O’Brien JM, Dungan K, Phillips G, Marsh CB, Lemeshow S, et al. Glucose variability and mortality in patients with sepsis. Crit Care Med. 2008;36(8):2316–21.
Article PubMed PubMed Central Google Scholar
Bagshaw SM, Bellomo R, Jacka MJ, Egi M, Hart GK, George C, et al. The impact of early hypoglycemia and blood glucose variability on outcome in critical Illness. Crit Care. 2009;13(3):R91.
Article PubMed PubMed Central Google Scholar
Chao WC, Tseng CH, Wu CL, Shih SJ, Yi CY, Chan MC. Higher glycemic variability within the first day of ICU admission is associated with increased 30-day mortality in ICU patients with sepsis. Ann Intensive Care. 2020;10(1):17.
Article PubMed PubMed Central Google Scholar
Kalfon P, Le Manach Y, Ichai C, Bréchot N, Cinotti R, Dequin PF, et al. Severe and multiple hypoglycemic episodes are associated with increased risk of death in ICU patients. Crit Care Lond Engl. 2015;19:153.
Badawi O, Waite MD, Fuhrman SA, Zuckerman IH. Association between intensive care unit–acquired dysglycemia and in-hospital mortality*. Crit Care Med. 2012;40(12):3180–8.
Krinsley JS, Egi M, Kiss A, Devendra AN, Schuetz P, Maurer PM, et al. Diabetic status and the relation of the three domains of glycemic control to mortality in critically ill patients: an international multicenter cohort study. Crit Care Lond Engl. 2013;17(2):R37.
Sechterberger MK, Bosman RJ, Oudemans-van Straaten HM, Siegelaar SE, Hermanides J, Hoekstra JBL, et al. The effect of Diabetes Mellitus on the association between measures of glycaemic control and ICU mortality: a retrospective cohort study. Crit Care Lond Engl. 2013;17(2):R52.
Unnikrishnan R, Misra A. Diabetes and COVID19: a bidirectional relationship. Nutr Diabetes. 2021;11(1):1–5.
Réa RR, Bernardelli RS, Kozesinski-Nakatani AC, Olandoski M, Martins-Junior MJ, Oliveira MC, et al. Dysglycemias in patients admitted to ICUs with severe acute respiratory syndrome due to COVID-19 versus other causes - a cohort study. BMC Pulm Med. 2023;23(1):173.
Article PubMed PubMed Central Google Scholar
Klein SJ, Fries D, Kaser S, Mathis S, Thomé C, Joannidis M. Unrecognized Diabetes in critically ill COVID-19 patients. Crit Care. 2020;24(1):406.
Article PubMed PubMed Central Google Scholar
Cariou B, Hadjadj S, Wargny M, Pichelin M, Al-Salameh A, Allix I, et al. Phenotypic characteristics and prognosis of inpatients with COVID-19 and Diabetes: the CORONADO study. Diabetologia. 2020;63(8):1500–15.
Article CAS PubMed PubMed Central Google Scholar
Xie W, Wu N, Wang B, Xu Y, Zhang Y, Xiang Y et al. Fasting plasma glucose and glucose fluctuation are associated with COVID-19 prognosis regardless of pre-existing diabetes. Diabetes Res Clin Pract [Internet]. 2021 Oct 1 [cited 2022 Jan 13];180. Available from: https://www.diabetesresearchclinicalpractice.com/article/S0168-8227(21)00400-9/fulltext.
Lazzeri C, Bonizzoli M, Batacchi S, Di Valvasone S, Chiostri M, Peris A. The prognostic role of hyperglycemia and glucose variability in covid-related acute respiratory distress syndrome. Diabetes Res Clin Pract. 2021;175:108789.
Article CAS PubMed PubMed Central Google Scholar
Tas J, van Gassel RJJ, Heines SJH, Mulder MMG, Heijnen NFL, Acampo-de Jong MJ et al. Serial measurements in COVID-19-induced acute Respiratory Disease to unravel heterogeneity of the Disease course: design of the Maastricht Intensive Care COVID cohort (MaastrICCht). BMJ Open. 2020;10(9).
Ghossein MA, Driessen RGH, van Rosmalen F, Sels JWEM, Delnoij T, Geyik Z, et al. Serial Assessment of Myocardial Injury markers in mechanically ventilated patients with SARS-CoV-2 (from the prospective MaastrICCht Cohort). Am J Cardiol. 2022;170:118–27.
Article CAS PubMed PubMed Central Google Scholar
Mulder MMG, Brandts Li, Brüggemann RAG, Koelmann M, Streng AS, Olie RH, et al. Serial markers of coagulation and inflammation and the occurrence of clinical pulmonary thromboembolism in mechanically ventilated patients with SARS-CoV-2 Infection; the prospective maastricht intensive care COVID cohort. Thromb J. 2021;19(1):35.
Article CAS PubMed PubMed Central Google Scholar
Hulshof AM, Brüggemann RAG, Mulder MMG, van de Berg TW, Sels JWEM, Olie RH, et al. Serial EXTEM, FIBTEM, and tPA rotational thromboelastometry observations in the Maastricht Intensive Care COVID Cohort-Persistence of Hypercoagulability and Hypofibrinolysis despite Anticoagulation. Front Cardiovasc Med. 2021;8:654174.
Article CAS PubMed PubMed Central Google Scholar
Wilmes N, Hendriks CWE, Viets CTA, Cornelissen SJWM, van Mook WNKA, Cox-Brinkman J, et al. Structural under-reporting of informed consent, data handling and sharing, ethical approval, and application of Open Science principles as proxies for study quality conduct in COVID-19 research: a systematic scoping review. BMJ Glob Health. 2023;8(5):e012007.
Article PubMed PubMed Central Google Scholar
Prokop M, van Everdingen W, van Rees Vellinga T, van Quarles H, Stöger L, Beenen L, et al. CO-RADS: a categorical CT Assessment Scheme for patients suspected of having COVID-19—Definition and evaluation. Radiology. 2020;296(2):E97–104.
Elshof J, Hebbink RHJ, Duiverman ML, Hagmeijer R. High-flow nasal cannula for COVID-19 patients: risk of bio-aerosol dispersion. Eur Respir J [Internet]. 2020 Oct 1 [cited 2022 Jan 12];56(4). Available from: https://erj.ersjournals.com/content/56/4/2003004.
Mellado-Artigas R, Ferreyro BL, Angriman F, Hernández-Sanz M, Arruti E, Torres A, et al. High-flow nasal oxygen in patients with COVID-19-associated acute Respiratory Failure. Crit Care. 2021;25(1):58.
Article PubMed PubMed Central Google Scholar
Bels JLM, van Kuijk SMJ, Ghossein-Doha C, Tijssen FH, van Gassel RJJ, Tas J, et al. Decreased serial scores of severe organ failure assessments are associated with survival in mechanically ventilated patients; the prospective Maastricht Intensive Care COVID cohort. J Crit Care. 2021;62:38–45.
Article CAS PubMed Google Scholar
Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2021;384(8):693–704.
International Expert Committee Report on the Role of. The A1C assay in the diagnosis of Diabetes. Diabetes Care. 2009;32(7):1327–34.
Use of glycated haemoglobin. (HbA1c) in the diagnosis of Diabetes Mellitus. Diabetes Res Clin Pract. 2011;93(3):299–309.
Comments (0)